GEHCHAN NAJI 4

4 · Kyverna Therapeutics, Inc. · Filed Mar 17, 2026

AI-generated summary of this filing

Updated Mar 17, 2026

Kyverna (KYTX) CMO Gehchan Naji Receives Equity Awards

What Happened

Gehchan Naji, Chief Medical & Development Officer of Kyverna Therapeutics (KYTX), was granted equity on March 13, 2026: 18,000 restricted stock units (RSUs) and 105,000 derivative equity awards. Both grants are reported at $0 (typical for awards) and were disclosed on a Form 4 filed March 17, 2026. These are grants/awards (code A), not open-market purchases or sales.

Key Details

Transaction date: 2026-03-13; Form 4 filed: 2026-03-17 (filed timely).
Grants reported: 18,000 RSUs @ $0; 105,000 derivative equity awards @ $0.
Shares owned after transaction: not specified in this filing.
Footnote F1 (RSUs): 1/4 of RSUs vest on March 13, 2027, then 1/4 on each one-year anniversary thereafter (4-year annual vesting), subject to continued service.
Footnote F2 (derivative award): 1/4 vests on March 13, 2027, then 1/48th vests each month thereafter (standard 4-year schedule with 1-year cliff), subject to continued service.
Exhibit 24 (Power of Attorney) is included with the filing.

Context

These awards are typical retention/compensation grants and do not represent an open-market buy or sale. The derivative award will convert to common shares as it vests (per the vesting schedule); there is no indication of an immediate cashless sale or exercise in this filing. The filing was made within the required two business days after the transaction date.

Form 4

Period: 2026-03-13

See Remarks

Transactions

Award
Common Stock
[F1]
2026-03-13+18,000→ 18,000 total
Award
Stock Option (right to buy)
[F2]
2026-03-13+105,000→ 105,000 total
Exercise: $8.95Exp: 2036-03-13→ Common Stock (105,000 underlying)

Footnotes (2)

[F1]Represents a restricted stock unit award of common stock and 1/4th of the shares underlying the restricted stock unit award shall vest on March 13, 2027 and an additional 1/4th of the shares underlying the restricted stock unit award shall vest on each one-year anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
[F2]1/4th of the shares subject to the option shall vest on March 13, 2027 and an additional 1/48th of the shares subject to the option shall vest on the same day of each month thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Signature

By: /s/ Marc Grasso, as Attorney-in-Fact|2026-03-17

2 files